Delivery Order SPE2DB22D3016-SPE2DB25FBDD4
- Not listed
- This is a $22,820.10 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a completion date of June 3, 2024. The contract was competitively awarded and is a firm fixed-price type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This is a $22,820.10 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the pharmaceutical product CABENUVA ER 600 MG-900 MG SUSP 6ML. It has an ultimate completion date of December 11, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly military and veterans' healthcare...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,901.40 firm-fixed-price contract is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has a period of performance through May 28, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $19,016.75, is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a specialty pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $15,267.60, is a Delivery Order with a Firm Fixed Price pricing type. The award is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has an ultimate completion date of February 12, 2025 and does not have a set-aside designation, indicating open competition....
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a ceiling value of $30,426.80 and a period of performance through April 17, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to...
- This is a $7,633.80 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a prescription medication. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 7, 2025. No set-aside designation was used for this open competition award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $43,665.88 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, awarded without set-aside provisions through competitive procurement, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contractor will perform the work at its corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $15,484.50 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDD4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,901.40 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension in 6 ml quantities. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 15, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child order under a larger contracting vehicle. No set-aside designation was applied to this procurement. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle provides comprehensive pharmaceutical support for military healthcare programs globally, enabling the company to supply a wide range of medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's status as a critical federal pharmaceutical distributor and its demonstrated capability to meet competitive procurement requirements position it as a key vendor for Defense Health Agency and other federal healthcare system needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.9k | 7/26/25 |